← Leaderboards
Mary Christine Playdon
University Of Utah
$2,092,255
Attributed
$4,633,315
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,633,315 · 3
By mechanism
U01$3,811,590 · 1
R00$747,000 · 1
R03$74,725 · 1
Top collaborators
- Scott A Summers7 shared
- Cornelia M Ulrich7 shared
Most similar at University Of Utah
Same institution · by research overlap
- Marilyn S. Nanney$4,771,232
- Carl S. Thummel$15,049,537
- Jared P Rutter$13,915,631
- William L Holland$8,337,489
- Mario R Capecchi$17,194,081
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicObesityCohortProspectiveMalignant NeoplasmsColorectal CancerLinkIncidencePublic HealthMetabolismMalignant Neoplasm Of ProstateMalignant Neoplasm Of OvarySerumBiologicalEpidemiologyDietSignal TransductionCancer PreventionPathway InteractionsMalignant Neoplasm Of LungCancer RiskBaseOverweightResources
Grant awards (11)
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$875,957
U01 · FY2025 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$68,468
U01 · FY2025 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2025 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$907,536
U01 · FY2024 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2024 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$950,923
U01 · FY2023 · CA · contact PI
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIH-Consortium of Metabolomics Studies (COMETS)$74,725
R03 · FY2023 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$913,866
U01 · FY2022 · CA · contact PI
Blood metabolite profiles and risk of developing endometrial cancer$249,000
R00 · FY2020 · CA · contact PI
Blood metabolite profiles and risk of developing endometrial cancer$249,000
R00 · FY2019 · CA · contact PI
Blood metabolite profiles and risk of developing endometrial cancer$249,000
R00 · FY2018 · CA · contact PI